文献速递细菌感染、耐药与抗菌药物医院感染防控

英国抗菌化疗学会耐药监测项目的应用与获益:传承与未来

Applications and benefits of the British Society for Antimicrobial Chemotherapy Resistance Surveillance Project-legacy and future.
PubMed 文献 · J Antimicrob Chemother · 2025-01-01

BSAC耐药监测项目于1999至2019年在英国和爱尔兰开展,收集了近10万株血流和呼吸道感染细菌分离株,通过标准化药敏试验提供MIC和敏感率数据,用于追踪耐药趋势、支持感染防控和抗菌药物管理,该项目已停止,菌株保藏于邓迪大学。

要点

  • 项目累计近10万株血流和呼吸道感染细菌分离株,提供MIC和敏感率数据。
  • 数据用于监测耐药趋势、识别影响因素并支持感染防控与抗菌药物管理。
  • 菌株资源(含测序和人口学信息)可通过Tayside生物样本库获取。

核心结论

  • BSAC耐药监测项目为耐药流行病学、感染防控和抗菌药物管理提供了重要数据和菌株资源,其遗留生物资源可供未来研究使用。

研究设计与样本

  • 项目于1999至2019年在英国和爱尔兰开展,收集了近10万株血流和下呼吸道感染细菌分离株。
  • 采用BSAC标准化药敏试验方法,报告每种细菌/抗生素组合的MIC和敏感率。

主要发现

  • 项目估算了收集组内物种流行率及抗菌药物耐药水平,以MIC和敏感率表示。
  • 数据用于监测和识别耐药趋势的影响因素,并分析特定地区、场所和患者人群的耐药模式。
  • 项目数据已发表多篇同行评议论文,并促进了医院微生物实验室药敏试验的标准化。

关键数值与推荐

  • 项目期间收集了近10万株细菌分离株,来自血流和呼吸道感染。
  • 药敏结果以MIC和敏感率呈现,覆盖每种测试的细菌/抗生素组合。

临床怎么用

  • 临床微生物实验室可参考BSAC标准化药敏方法提高检测一致性。
  • 研究者可通过Tayside生物样本库获取菌株及数据用于耐药研究。

局限性

  • 项目已于2019年停止,因公共卫生实验室监测系统日益全面。
  • 原文未报告样本的具体人群构成和耐药率数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The BSAC Resistance Surveillance Project ran from 1999 to 2019, amassing an unrivalled collection of almost 100 000 bacterial isolates from bloodstream and lower respiratory tract infections in the UK and Ireland. It was initiated in response to increasing antimicrobial resistance and supplemented existing surveillance schemes, enhancing the understanding of resistance epidemiology by estimating species prevalence within collection groups together with levels of antibacterial resistance, presented in terms of MICs and percentage susceptibility for each species/antibiotic combination tested. Generated data were explored to monitor and identify factors shaping resistance trends, and to profile antibacterial resistance patterns in specific geographies, settings and patient populations. The release of data and/or bacterial isolates led to a rich repository of published peer-reviewed papers. Additionally, the promotion of the BSAC standardized susceptibility testing method resulted in greater uniformity of antimicrobial susceptibility testing in hospital microbiology laboratories. Over time, public health laboratories' surveillance systems became increasingly comprehensive, and the BSAC Project ceased in 2019. This invaluable collection is now housed in the University of Dundee, in collaboration with the University of St Andrews. We highlight the collection's unique timeliness, and how the BSAC Project contributed to key interventions for infection prevention and control, public health and antimicrobial stewardship. We demonstrate the utility and benefits of the Project outlining the collection's future applications as an important bioresource. It comprises well-defined bacterial isolates-many now sequenced-with MIC data and demographic information. This legacy is available to researchers via the Tayside Biorepository and custodian contacts.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Parcell BJ, Horner C, Reynolds R, et al. Applications and benefits of the British Society for Antimicrobial Chemotherapy Resistance Surveillance Project-legacy and future. J Antimicrob Chemother. 2025. PMID: 41140269. doi:10.1093/jac/dkaf314

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。